SCHEMBL26192598

SCHEMBL26192598

CC(C)(C)c1ccc2sc3cc(CC(C)(C)c4ccc5c(c4)sc4ccccc45)ccc3c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
ALDH1A1 P00352 3/20 0.41
RAB9A P51151 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTPN22 Q9Y2R2 2/20 0.40
PTPN7 P35236 1/20 0.40
DUSP3 P51452 1/20 0.40
PTPN12 Q05209 1/20 0.40
KIF11 P52732 2/20 0.38
APEX1 P27695 1/20 0.38
GPR3 P46089 1/20 0.36
PGR P06401 1/20 0.33
RORA P35398 1/20 0.33
RORC P51449 1/20 0.33
RORB Q92753 1/20 0.33
CYP1A2 P05177 1/20 0.33
DHODH Q02127 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21084699 1.00 MAPT (0.41) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL22939799 0.97 ALDH1A1 (0.41) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL19866411 0.86 APEX1 (0.37) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL24450352 0.86 PTPN7 (0.36) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23318752 0.85 TNF (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL24817882 0.85 PTPN22 (0.37) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23917795 0.84 ALDH1A1 (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23773110 0.84 APEX1 (0.39) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL24601597 0.83 RAB9A (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL24848814 0.83 APEX1 (0.38) MAPTALDH1A1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242484-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242484-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS USING SAME MNS1, NSFL1C, NCF1 MAPT 3712/4885ALDH1A1 1218/4885RAB9A 2438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.